Paper42101807
Unraveling the therapeutic potential of luteolin in renal pathology: a comprehensive pathway oriented approach.
Singh L and 3 others. Pharmacol Rep, 2026. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Unraveling the therapeutic potential of luteolin in renal pathology: a comprehensive pathway oriented approach. Papers, record 42101807. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42101807
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Unraveling the therapeutic potential of luteolin in renal pathology: a comprehensive pathway oriented approach.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References76
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40599626 | The burden of acute kidney disease: an epidemiological review and importance of follow-up care. | Clin Kidney J | 2025 | https://conductscience.org/library/papers/40599626 | PubMed |
| 2 | 37165615 | Acute kidney disease: an overview of the epidemiology, pathophysiology, and management. | Kidney Res Clin Pract | 2023 | https://conductscience.org/library/papers/37165615 | PubMed |
| 3 | 38365413 | An update on the global disparities in kidney disease burden and care across world countries and regions. | Lancet Glob Health | 2024 | https://conductscience.org/library/papers/38365413 | PubMed |
| 4 | 39199307 | Endoplasmic Reticulum Stress-Mediated Cell Death in Renal Fibrosis. | Biomolecules | 2024 | https://conductscience.org/library/papers/39199307 | PubMed |
| 5 | 41150801 | The Pathogenesis of Chronic Kidney Disease (CKD) and the Preventive and Therapeutic Effects of Natural Products. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/41150801 | PubMed |
| 6 | 32082479 | Oxidative Stress in the Pathophysiology of Kidney Disease: Implications for Noninvasive Monitoring and Identification of Biomarkers. | Oxid Med Cell Longev | 2020 | https://conductscience.org/library/papers/32082479 | PubMed |
| 7 | 37569752 | Diabetic Nephropathy: Significance of Determining Oxidative Stress and Opportunities for Antioxidant Therapies. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37569752 | PubMed |
| 8 | 30248418 | Nrf2 activator for the treatment of kidney diseases. | Toxicol Appl Pharmacol | 2018 | https://conductscience.org/library/papers/30248418 | PubMed |
| 9 | 21189948 | Renal fibrosis. | Korean J Pediatr | 2010 | https://conductscience.org/library/papers/21189948 | PubMed |
| 10 | 16408108 | Renal fibrosis: new insights into the pathogenesis and therapeutics. | Kidney Int | 2006 | https://conductscience.org/library/papers/16408108 | PubMed |
| 11 | 29740333 | Flavonoids in Kidney Health and Disease. | Front Physiol | 2018 | https://conductscience.org/library/papers/29740333 | PubMed |
| 12 | 26361743 | Luteolin as an anti-inflammatory and neuroprotective agent: A brief review. | Brain Res Bull | 2015 | https://conductscience.org/library/papers/26361743 | PubMed |
| 13 | 39165588 | Recent insights into luteolin and its biological and pharmacological activities. | EXCLI J | 2024 | https://conductscience.org/library/papers/39165588 | PubMed |
| 14 | 36358895 | Renoprotective Effects of Luteolin: Therapeutic Potential for COVID-19-Associated Acute Kidney Injuries. | Biomolecules | 2022 | https://conductscience.org/library/papers/36358895 | PubMed |
| 15 | 37713990 | Luteolin as a potential hepatoprotective drug: Molecular mechanisms and treatment strategies. | Biomed Pharmacother | 2023 | https://conductscience.org/library/papers/37713990 | PubMed |
| 16 | 39100967 | Luteolin Alleviates Diabetic Nephropathy Fibrosis Involving AMPK/NLRP3/TGF-β Pathway. | Diabetes Metab Syndr Obes | 2024 | https://conductscience.org/library/papers/39100967 | PubMed |
| 17 | 39479625 | Luteolin ameliorates hyperuricemic nephropathy by activating urate excretion and Nrf2/HO-1/NQO1 antioxidant pathways in mice. | Food Sci Nutr | 2024 | https://conductscience.org/library/papers/39479625 | PubMed |
| 18 | 33827303 | Luteolin attenuates doxorubicin-induced derangements of liver and kidney by reducing oxidative and inflammatory stress to suppress apoptosis. | Hum Exp Toxicol | 2021 | https://conductscience.org/library/papers/33827303 | PubMed |
| 19 | 31091348 | Protective role of luteolin against bisphenol A-induced renal toxicity through suppressing oxidative stress, inflammation, and upregulating Nrf2/ARE/ HO-1 pathway. | IUBMB Life | 2019 | https://conductscience.org/library/papers/31091348 | PubMed |
| 20 | 25587925 | Luteolin attenuate the D-galactose-induced renal damage by attenuation of oxidative stress and inflammation. | Nat Prod Res | 2015 | https://conductscience.org/library/papers/25587925 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42939744 | Edaravone for Potential Mitigation of Oxidative Stress and Inflammation in Kidney Disease. | Biomolecules | 2026 | https://conductscience.org/library/papers/42939744 | PubMed |
| 42824465 | Mentha-mediated selenium nanoparticles attenuate adriamycin-induced chronic kidney disease via multi-target modulation of oxidative, inflammatory, and fibrotic pathways. | Biomater Biosyst | 2026 | https://conductscience.org/library/papers/42824465 | PubMed |
| 42769453 | Bruceine A attenuates renal tubulointerstitial fibrosis by inhibiting the Wnt7a/PI3K/AKT pathway. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42769453 | PubMed |
| 42712548 | Effects and potential mechanisms of astragaloside IV in animal models of renal fibrosis: a systematic review and meta-analysis. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42712548 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42101807
GET https://conductscience.org/api/papers/v1/42101807/references?page=2